

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of MHC class II biosynthetic process (GO:0045346) | 9.36641951 |
| 2 | regulation of cytokine secretion involved in immune response (GO:0002739) | 8.65282085 |
| 3 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 8.45769840 |
| 4 | response to inactivity (GO:0014854) | 8.10366658 |
| 5 | negative regulation of interleukin-12 production (GO:0032695) | 8.02746158 |
| 6 | cytidine metabolic process (GO:0046087) | 7.67672687 |
| 7 | cytidine catabolic process (GO:0006216) | 7.67672687 |
| 8 | cytidine deamination (GO:0009972) | 7.67672687 |
| 9 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 7.47761498 |
| 10 | tolerance induction (GO:0002507) | 7.32733444 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.28428480 |
| 12 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.16655981 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.13516397 |
| 14 | negative regulation of cell killing (GO:0031342) | 7.13516397 |
| 15 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 7.08936172 |
| 16 | * negative regulation of B cell proliferation (GO:0030889) | 7.03367236 |
| 17 | regulation of isotype switching (GO:0045191) | 6.88623459 |
| 18 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.48300381 |
| 19 | DNA deamination (GO:0045006) | 6.11662908 |
| 20 | response to interleukin-15 (GO:0070672) | 6.09468502 |
| 21 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 6.04746961 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 5.98137131 |
| 23 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 5.87802779 |
| 24 | negative T cell selection (GO:0043383) | 5.85987777 |
| 25 | negative thymic T cell selection (GO:0045060) | 5.72708579 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.48611708 |
| 27 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 5.35111701 |
| 28 | negative regulation of T-helper cell differentiation (GO:0045623) | 5.35111701 |
| 29 | glial cell proliferation (GO:0014009) | 5.34123300 |
| 30 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 5.25748102 |
| 31 | negative regulation of cytokine production involved in immune response (GO:0002719) | 5.22128832 |
| 32 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 5.18371557 |
| 33 | regulation of tolerance induction (GO:0002643) | 4.97695094 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90345504 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.82330394 |
| 36 | positive thymic T cell selection (GO:0045059) | 4.80503979 |
| 37 | thymic T cell selection (GO:0045061) | 4.80266779 |
| 38 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.78575005 |
| 39 | regulation of immunoglobulin production (GO:0002637) | 4.74588957 |
| 40 | T cell selection (GO:0045058) | 4.68752748 |
| 41 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.63634002 |
| 42 | T-helper cell differentiation (GO:0042093) | 4.63634002 |
| 43 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.63454909 |
| 44 | regulation of B cell mediated immunity (GO:0002712) | 4.62775781 |
| 45 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 4.60413215 |
| 46 | positive T cell selection (GO:0043368) | 4.57448974 |
| 47 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.54663774 |
| 48 | regulation of interferon-alpha production (GO:0032647) | 4.54346338 |
| 49 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 4.51383093 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.45467369 |
| 51 | regulation of B cell apoptotic process (GO:0002902) | 4.43420178 |
| 52 | T cell lineage commitment (GO:0002360) | 4.37255594 |
| 53 | * negative regulation of B cell activation (GO:0050869) | 4.36527011 |
| 54 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.36494749 |
| 55 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.34493922 |
| 56 | cytoplasmic sequestering of transcription factor (GO:0042994) | 4.29185461 |
| 57 | B cell proliferation (GO:0042100) | 4.28375235 |
| 58 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 4.27472360 |
| 59 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.20711000 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 4.19192895 |
| 61 | leukocyte aggregation (GO:0070486) | 4.18463372 |
| 62 | * regulation of regulatory T cell differentiation (GO:0045589) | 4.18127172 |
| 63 | activated T cell proliferation (GO:0050798) | 4.17923710 |
| 64 | * regulation of B cell proliferation (GO:0030888) | 4.16689146 |
| 65 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.14431105 |
| 66 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.14431105 |
| 67 | negative regulation of adaptive immune response (GO:0002820) | 4.14298635 |
| 68 | positive regulation of isotype switching (GO:0045830) | 4.13954075 |
| 69 | regulation of interleukin-13 production (GO:0032656) | 4.07975919 |
| 70 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.05201022 |
| 71 | T cell differentiation involved in immune response (GO:0002292) | 4.03117738 |
| 72 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.03117738 |
| 73 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.03117738 |
| 74 | negative regulation of growth of symbiont in host (GO:0044130) | 3.98031481 |
| 75 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.98031481 |
| 76 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.98031481 |
| 77 | regulation of growth of symbiont in host (GO:0044126) | 3.98031481 |
| 78 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.95919455 |
| 79 | negative regulation of interferon-gamma production (GO:0032689) | 3.91928423 |
| 80 | positive regulation of cell killing (GO:0031343) | 3.90752167 |
| 81 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.87184859 |
| 82 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.86136868 |
| 83 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.82163606 |
| 84 | negative regulation of T cell apoptotic process (GO:0070233) | 3.81744617 |
| 85 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.78191951 |
| 86 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.76352040 |
| 87 | * lymphocyte costimulation (GO:0031294) | 3.75753451 |
| 88 | T cell receptor signaling pathway (GO:0050852) | 3.72087763 |
| 89 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.71134596 |
| 90 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.70582366 |
| 91 | myeloid dendritic cell differentiation (GO:0043011) | 3.66957847 |
| 92 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.65924253 |
| 93 | myeloid dendritic cell activation (GO:0001773) | 3.65617086 |
| 94 | cytoplasmic sequestering of protein (GO:0051220) | 3.65425777 |
| 95 | regulation of cell killing (GO:0031341) | 3.62768988 |
| 96 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.62675780 |
| 97 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59572236 |
| 98 | positive regulation of defense response to virus by host (GO:0002230) | 3.59519870 |
| 99 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.56938001 |
| 100 | interferon-gamma production (GO:0032609) | 3.52597466 |
| 101 | positive regulation of interleukin-4 production (GO:0032753) | 3.52398248 |
| 102 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.52282947 |
| 103 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.51948076 |
| 104 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.51948076 |
| 105 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.51933531 |
| 106 | positive regulation of DNA recombination (GO:0045911) | 3.51809123 |
| 107 | negative regulation by host of viral transcription (GO:0043922) | 3.51363849 |
| 108 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.50841410 |
| 109 | negative regulation of cytokine biosynthetic process (GO:0042036) | 3.49447817 |
| 110 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.49167509 |
| 111 | negative regulation of viral genome replication (GO:0045071) | 3.49075941 |
| 112 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.46787110 |
| 113 | T cell migration (GO:0072678) | 3.45459096 |
| 114 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.43590851 |
| 115 | positive regulation of tolerance induction (GO:0002645) | 3.40208642 |
| 116 | positive regulation of T cell chemotaxis (GO:0010820) | 3.40048377 |
| 117 | regulation of T cell chemotaxis (GO:0010819) | 3.40048377 |
| 118 | positive regulation of leukocyte apoptotic process (GO:2000108) | 3.39086771 |
| 119 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.38982817 |
| 120 | regulation of gamma-delta T cell activation (GO:0046643) | 3.38957723 |
| 121 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.37325228 |
| 122 | alpha-beta T cell differentiation (GO:0046632) | 3.36966506 |
| 123 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.36675379 |
| 124 | corticosteroid receptor signaling pathway (GO:0031958) | 3.34659616 |
| 125 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34604560 |
| 126 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.34567478 |
| 127 | growth hormone receptor signaling pathway (GO:0060396) | 3.33745834 |
| 128 | positive regulation of lymphocyte migration (GO:2000403) | 3.32799832 |
| 129 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.31514650 |
| 130 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.30385144 |
| 131 | * T cell costimulation (GO:0031295) | 3.29294023 |
| 132 | eosinophil chemotaxis (GO:0048245) | 3.26731932 |
| 133 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.24195480 |
| 134 | * negative regulation of T cell proliferation (GO:0042130) | 3.24146009 |
| 135 | positive regulation of activated T cell proliferation (GO:0042104) | 3.23157598 |
| 136 | alpha-beta T cell activation (GO:0046631) | 3.22970709 |
| 137 | negative regulation of osteoclast differentiation (GO:0045671) | 3.22281033 |
| 138 | regulation of interleukin-2 production (GO:0032663) | 3.21141402 |
| 139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.19660486 |
| 140 | regulation of B cell differentiation (GO:0045577) | 3.19490167 |
| 141 | positive regulation of interleukin-2 production (GO:0032743) | 3.19181592 |
| 142 | positive regulation of B cell differentiation (GO:0045579) | 3.17511020 |
| 143 | regulation of interleukin-4 production (GO:0032673) | 3.17226733 |
| 144 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.17211884 |
| 145 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.15974090 |
| 146 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.15662430 |
| 147 | T cell homeostasis (GO:0043029) | 3.15175725 |
| 148 | chemokine-mediated signaling pathway (GO:0070098) | 3.14071493 |
| 149 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.13442009 |
| 150 | * negative regulation of T cell activation (GO:0050868) | 3.12944383 |
| 151 | regulation of activation of Janus kinase activity (GO:0010533) | 3.12299932 |
| 152 | defense response to protozoan (GO:0042832) | 3.11697439 |
| 153 | lymphocyte chemotaxis (GO:0048247) | 3.09688392 |
| 154 | T cell differentiation (GO:0030217) | 3.09063750 |
| 155 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.04349298 |
| 156 | regulation of chronic inflammatory response (GO:0002676) | 12.8907083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.54765480 |
| 2 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.73437117 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.59965601 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.21018399 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.81104647 |
| 6 | * MYB_26560356_Chip-Seq_TH2_Human | 3.46084298 |
| 7 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.35159329 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.28492324 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.97217123 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.94105209 |
| 11 | * MAF_26560356_Chip-Seq_TH1_Human | 2.85619858 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.75719339 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.73770268 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67291290 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.64889324 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.49615987 |
| 17 | * MYB_26560356_Chip-Seq_TH1_Human | 2.47322846 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45792511 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.35514779 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30080578 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22786589 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.15838869 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.08406782 |
| 24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.04600176 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.04564771 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02722817 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02048308 |
| 28 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 10.3636011 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.99467057 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99418590 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97990508 |
| 32 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75837712 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73890783 |
| 34 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68254172 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66951524 |
| 36 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.65479132 |
| 37 | * MAF_26560356_Chip-Seq_TH2_Human | 1.59594232 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59174321 |
| 39 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.57381791 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55539088 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.55000041 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53961950 |
| 43 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.53848787 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.53331529 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51153461 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.50289370 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46274670 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45674421 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43366017 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42841346 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42819314 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41510711 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39579928 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38294015 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32155853 |
| 56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26689168 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.25730691 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24872638 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24512864 |
| 60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21654038 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17896999 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17867209 |
| 63 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.15437673 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11868053 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11677305 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11117720 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10025035 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09041368 |
| 69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08798046 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08793475 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07894991 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07863964 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07593845 |
| 74 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04170733 |
| 75 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.02674489 |
| 76 | GATA3_26560356_Chip-Seq_TH1_Human | 1.02554203 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02414272 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99415459 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96109075 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92747257 |
| 81 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.90633548 |
| 82 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87161394 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85443551 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84530875 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84020775 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82775226 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82361519 |
| 88 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.81317996 |
| 89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80295970 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77873875 |
| 91 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.77714945 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77375142 |
| 93 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.76593816 |
| 94 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.75597440 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74755697 |
| 96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73652565 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73034542 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73014546 |
| 99 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72418493 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72270624 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71482348 |
| 102 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.71450977 |
| 103 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.71205230 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69366082 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.66542705 |
| 106 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66527437 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66214209 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66113243 |
| 109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.66040960 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65678659 |
| 111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64963945 |
| 112 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.64772027 |
| 113 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.64620642 |
| 114 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.63713001 |
| 115 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63157729 |
| 116 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.62256731 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62194315 |
| 118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.61864036 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.61713177 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61535420 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.61053939 |
| 122 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.60855612 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60384601 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 0.58680694 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 0.58528520 |
| 126 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.58299929 |
| 127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57474162 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.55575845 |
| 129 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.55141632 |
| 130 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.55103691 |
| 131 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.55026551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 7.84024487 |
| 2 | MP0003300_gastrointestinal_ulcer | 7.00467888 |
| 3 | MP0005671_abnormal_response_to | 5.09632335 |
| 4 | MP0003763_abnormal_thymus_physiology | 4.51264228 |
| 5 | MP0001790_abnormal_immune_system | 2.97537256 |
| 6 | MP0005387_immune_system_phenotype | 2.97537256 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.92660371 |
| 8 | * MP0001873_stomach_inflammation | 2.78187361 |
| 9 | MP0006082_CNS_inflammation | 2.72097454 |
| 10 | MP0001348_abnormal_lacrimal_gland | 2.55948386 |
| 11 | * MP0001800_abnormal_humoral_immune | 2.52284982 |
| 12 | MP0002332_abnormal_exercise_endurance | 2.34601329 |
| 13 | MP0003724_increased_susceptibility_to | 2.29257094 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.22059226 |
| 15 | * MP0005000_abnormal_immune_tolerance | 2.20706643 |
| 16 | MP0001542_abnormal_bone_strength | 2.13403545 |
| 17 | MP0000490_abnormal_crypts_of | 2.08140655 |
| 18 | MP0003436_decreased_susceptibility_to | 2.04320450 |
| 19 | MP0002277_abnormal_respiratory_mucosa | 2.00996295 |
| 20 | MP0001501_abnormal_sleep_pattern | 1.99232413 |
| 21 | MP0004947_skin_inflammation | 1.98785782 |
| 22 | * MP0002723_abnormal_immune_serum | 1.98348182 |
| 23 | MP0009785_altered_susceptibility_to | 1.95883416 |
| 24 | MP0003866_abnormal_defecation | 1.93435382 |
| 25 | MP0005025_abnormal_response_to | 1.90056012 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.86977083 |
| 27 | * MP0002452_abnormal_antigen_presenting | 1.83291112 |
| 28 | MP0001919_abnormal_reproductive_system | 1.81395696 |
| 29 | MP0004510_myositis | 1.80722875 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.80683241 |
| 31 | * MP0002420_abnormal_adaptive_immunity | 1.77829628 |
| 32 | * MP0002398_abnormal_bone_marrow | 1.76863177 |
| 33 | * MP0001819_abnormal_immune_cell | 1.75969795 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.75046393 |
| 35 | * MP0000703_abnormal_thymus_morphology | 1.66734629 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.62915731 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.59585817 |
| 38 | * MP0000716_abnormal_immune_system | 1.57922881 |
| 39 | MP0000685_abnormal_immune_system | 1.57755979 |
| 40 | MP0003075_altered_response_to | 1.56785919 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.53032497 |
| 42 | MP0005023_abnormal_wound_healing | 1.49776560 |
| 43 | * MP0002405_respiratory_system_inflammati | 1.48116526 |
| 44 | MP0002163_abnormal_gland_morphology | 1.45646286 |
| 45 | * MP0001663_abnormal_digestive_system | 1.43980141 |
| 46 | * MP0002722_abnormal_immune_system | 1.40277534 |
| 47 | * MP0001845_abnormal_inflammatory_respons | 1.37661990 |
| 48 | * MP0002933_joint_inflammation | 1.31778232 |
| 49 | MP0000343_altered_response_to | 1.31501690 |
| 50 | MP0005165_increased_susceptibility_to | 1.31209239 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.29568438 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.24796178 |
| 53 | * MP0000689_abnormal_spleen_morphology | 1.18017876 |
| 54 | MP0001881_abnormal_mammary_gland | 1.16842686 |
| 55 | * MP0002429_abnormal_blood_cell | 1.16732156 |
| 56 | MP0002006_tumorigenesis | 1.16559105 |
| 57 | MP0002419_abnormal_innate_immunity | 1.15295615 |
| 58 | * MP0005310_abnormal_salivary_gland | 1.10316638 |
| 59 | MP0002009_preneoplasia | 1.06116488 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.06004881 |
| 61 | MP0001764_abnormal_homeostasis | 1.02026505 |
| 62 | MP0010307_abnormal_tumor_latency | 0.99158436 |
| 63 | MP0002396_abnormal_hematopoietic_system | 0.98803055 |
| 64 | MP0005076_abnormal_cell_differentiation | 0.96190129 |
| 65 | MP0003448_altered_tumor_morphology | 0.95604799 |
| 66 | MP0000569_abnormal_digit_pigmentation | 0.95551358 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.95504472 |
| 68 | MP0003786_premature_aging | 0.94979904 |
| 69 | MP0008469_abnormal_protein_level | 0.94519373 |
| 70 | MP0008872_abnormal_physiological_respon | 0.93373136 |
| 71 | MP0000477_abnormal_intestine_morphology | 0.91933396 |
| 72 | * MP0005381_digestive/alimentary_phenotyp | 0.91887446 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.87626073 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 0.87626073 |
| 75 | MP0000013_abnormal_adipose_tissue | 0.87607953 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.86518705 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.86018088 |
| 78 | MP0000627_abnormal_mammary_gland | 0.85130476 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 0.83493449 |
| 80 | MP0009764_decreased_sensitivity_to | 0.79465218 |
| 81 | MP0003795_abnormal_bone_structure | 0.79213033 |
| 82 | MP0005389_reproductive_system_phenotype | 0.76453049 |
| 83 | * MP0001853_heart_inflammation | 0.71937071 |
| 84 | MP0002998_abnormal_bone_remodeling | 0.71451285 |
| 85 | MP0008569_lethality_at_weaning | 0.70743394 |
| 86 | MP0004084_abnormal_cardiac_muscle | 0.70225947 |
| 87 | MP0000372_irregular_coat_pigmentation | 0.69948453 |
| 88 | MP0009763_increased_sensitivity_to | 0.68940904 |
| 89 | MP0001851_eye_inflammation | 0.66715912 |
| 90 | * MP0002693_abnormal_pancreas_physiology | 0.65985704 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.65594389 |
| 92 | MP0008874_decreased_physiological_sensi | 0.62625707 |
| 93 | MP0000371_diluted_coat_color | 0.62308333 |
| 94 | MP0005266_abnormal_metabolism | 0.61515777 |
| 95 | MP0008873_increased_physiological_sensi | 0.61285211 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.60870968 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.58605139 |
| 98 | MP0005166_decreased_susceptibility_to | 0.58213442 |
| 99 | MP0005390_skeleton_phenotype | 0.58135635 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.58036380 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.55117046 |
| 102 | MP0000858_altered_metastatic_potential | 0.53853767 |
| 103 | MP0001958_emphysema | 0.52024487 |
| 104 | MP0000604_amyloidosis | 0.50896937 |
| 105 | MP0004381_abnormal_hair_follicle | 0.49258416 |
| 106 | MP0008057_abnormal_DNA_replication | 0.48994790 |
| 107 | MP0005197_abnormal_uvea_morphology | 0.48395571 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.47784889 |
| 109 | MP0003045_fibrosis | 0.47734431 |
| 110 | MP0000609_abnormal_liver_physiology | 0.47308364 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.47150642 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.46591477 |
| 113 | MP0002733_abnormal_thermal_nociception | 0.46582321 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.46569211 |
| 115 | MP0002254_reproductive_system_inflammat | 0.46148785 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.44525240 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.44361255 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43799767 |
| 119 | * MP0000249_abnormal_blood_vessel | 0.43512276 |
| 120 | MP0005595_abnormal_vascular_smooth | 0.43217311 |
| 121 | MP0005535_abnormal_body_temperature | 0.43146496 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.41279976 |
| 123 | MP0002098_abnormal_vibrissa_morphology | 0.41174633 |
| 124 | MP0008995_early_reproductive_senescence | 0.40642893 |
| 125 | MP0004145_abnormal_muscle_electrophysio | 0.40040761 |
| 126 | MP0005174_abnormal_tail_pigmentation | 0.39065997 |
| 127 | MP0001191_abnormal_skin_condition | 0.38881946 |
| 128 | MP0000367_abnormal_coat/_hair | 0.37563299 |
| 129 | MP0005451_abnormal_body_composition | 0.37213394 |
| 130 | MP0002168_other_aberrant_phenotype | 0.37124597 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.35693631 |
| 132 | MP0003806_abnormal_nucleotide_metabolis | 0.35570617 |
| 133 | * MP0002083_premature_death | 0.35468810 |
| 134 | MP0002095_abnormal_skin_pigmentation | 0.33099843 |
| 135 | MP0003868_abnormal_feces_composition | 0.33095114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 9.44363096 |
| 2 | Keratoconjunctivitis sicca (HP:0001097) | 8.11393326 |
| 3 | Keratoconjunctivitis (HP:0001096) | 7.45094468 |
| 4 | Arterial thrombosis (HP:0004420) | 6.75540013 |
| 5 | * Pulmonary infiltrates (HP:0002113) | 5.44360424 |
| 6 | * Gangrene (HP:0100758) | 5.02569103 |
| 7 | * Pulmonary embolism (HP:0002204) | 4.94262625 |
| 8 | * Hemoptysis (HP:0002105) | 4.89368016 |
| 9 | Increased IgM level (HP:0003496) | 4.89337084 |
| 10 | T lymphocytopenia (HP:0005403) | 4.79953371 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.53457730 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.46513828 |
| 13 | Encephalitis (HP:0002383) | 4.43846204 |
| 14 | Anorexia (HP:0002039) | 4.27547377 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 4.23158400 |
| 16 | * Vasculitis (HP:0002633) | 4.10839904 |
| 17 | Aplastic anemia (HP:0001915) | 3.90566439 |
| 18 | Agammaglobulinemia (HP:0004432) | 3.83664652 |
| 19 | Hypoproteinemia (HP:0003075) | 3.82763635 |
| 20 | * Thrombophlebitis (HP:0004418) | 3.82675778 |
| 21 | Combined immunodeficiency (HP:0005387) | 3.71329956 |
| 22 | IgM deficiency (HP:0002850) | 3.61300305 |
| 23 | Fatigue (HP:0012378) | 3.61031726 |
| 24 | Hypoplasia of the thymus (HP:0000778) | 3.60931341 |
| 25 | * Glomerulopathy (HP:0100820) | 3.59984648 |
| 26 | Abnormality of T cells (HP:0002843) | 3.47775807 |
| 27 | Keratitis (HP:0000491) | 3.47458676 |
| 28 | Recurrent skin infections (HP:0001581) | 3.36805051 |
| 29 | * Abnormality of the pericardium (HP:0001697) | 3.34849511 |
| 30 | Eosinophilia (HP:0001880) | 3.30268732 |
| 31 | * Meningitis (HP:0001287) | 3.23392271 |
| 32 | Stomatitis (HP:0010280) | 3.22039499 |
| 33 | Abnormality of B cell number (HP:0010975) | 3.21126376 |
| 34 | B lymphocytopenia (HP:0010976) | 3.21126376 |
| 35 | Eczematoid dermatitis (HP:0000976) | 3.16702352 |
| 36 | Granulocytopenia (HP:0001913) | 3.15503889 |
| 37 | Pustule (HP:0200039) | 3.13794602 |
| 38 | * Abnormality of the pleura (HP:0002103) | 3.10591271 |
| 39 | IgA deficiency (HP:0002720) | 3.09080485 |
| 40 | Recurrent bronchitis (HP:0002837) | 3.01403629 |
| 41 | * Polyneuropathy (HP:0001271) | 2.97310312 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93696252 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.90739879 |
| 44 | Vertigo (HP:0002321) | 2.89812125 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.85809537 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.85006871 |
| 47 | Joint swelling (HP:0001386) | 2.69045176 |
| 48 | Abnormality of the endocardium (HP:0004306) | 2.65022873 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.62121629 |
| 50 | Chronic diarrhea (HP:0002028) | 2.61277103 |
| 51 | Aseptic necrosis (HP:0010885) | 2.60576369 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.59582169 |
| 53 | Gingival bleeding (HP:0000225) | 2.56556826 |
| 54 | Acne (HP:0001061) | 2.56080995 |
| 55 | * Chest pain (HP:0100749) | 2.53699090 |
| 56 | * Pancreatitis (HP:0001733) | 2.53280960 |
| 57 | Amaurosis fugax (HP:0100576) | 2.48923289 |
| 58 | Recurrent otitis media (HP:0000403) | 2.44468991 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.42154864 |
| 60 | IgG deficiency (HP:0004315) | 2.39575189 |
| 61 | Recurrent viral infections (HP:0004429) | 2.37766607 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.34970750 |
| 63 | * Paresthesia (HP:0003401) | 2.32949515 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.30253538 |
| 65 | Increased intracranial pressure (HP:0002516) | 2.27386334 |
| 66 | Abnormality of intracranial pressure (HP:0012640) | 2.27386334 |
| 67 | Diplopia (HP:0000651) | 2.26622420 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.26622420 |
| 69 | * Cerebral ischemia (HP:0002637) | 2.23636190 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.17252011 |
| 71 | Thyroiditis (HP:0100646) | 2.14847075 |
| 72 | Hypochromic anemia (HP:0001931) | 2.11575636 |
| 73 | Abnormal albumin level (HP:0012116) | 2.10097808 |
| 74 | Hypoalbuminemia (HP:0003073) | 2.10097808 |
| 75 | Abnormality of eosinophils (HP:0001879) | 2.06989769 |
| 76 | Autoimmune hemolytic anemia (HP:0001890) | 2.06744027 |
| 77 | Polycythemia (HP:0001901) | 2.05453225 |
| 78 | Leukocytosis (HP:0001974) | 2.05260177 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.03727957 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.02727852 |
| 81 | * Abnormality of the prostate (HP:0008775) | 2.02526856 |
| 82 | Thrombocytosis (HP:0001894) | 2.01850656 |
| 83 | * Skin rash (HP:0000988) | 2.00698443 |
| 84 | Optic neuritis (HP:0100653) | 12.5506948 |
| 85 | Retrobulbar optic neuritis (HP:0100654) | 12.5506948 |
| 86 | Orchitis (HP:0100796) | 10.9008015 |
| 87 | * Arthralgia (HP:0002829) | 1.97990554 |
| 88 | Menstrual irregularities (HP:0000858) | 1.96513017 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 1.95690014 |
| 90 | Verrucae (HP:0200043) | 1.95035847 |
| 91 | Papilloma (HP:0012740) | 1.95035847 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 1.93436440 |
| 93 | Abnormality of the fingertips (HP:0001211) | 1.92591263 |
| 94 | Seborrheic dermatitis (HP:0001051) | 1.92331619 |
| 95 | Abnormal platelet volume (HP:0011876) | 1.91311296 |
| 96 | Hemiplegia (HP:0002301) | 1.89995388 |
| 97 | Alveolar cell carcinoma (HP:0006519) | 1.86418702 |
| 98 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82029651 |
| 99 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82029651 |
| 100 | Lymphopenia (HP:0001888) | 1.81558963 |
| 101 | * Chronic obstructive pulmonary disease (HP:0006510) | 1.80803100 |
| 102 | * Obstructive lung disease (HP:0006536) | 1.80803100 |
| 103 | Hepatosplenomegaly (HP:0001433) | 1.78672216 |
| 104 | Ileus (HP:0002595) | 1.78476153 |
| 105 | Recurrent sinusitis (HP:0011108) | 1.78149451 |
| 106 | Oral leukoplakia (HP:0002745) | 1.77886327 |
| 107 | Increased mean platelet volume (HP:0011877) | 1.77600082 |
| 108 | Memory impairment (HP:0002354) | 1.77503067 |
| 109 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.75151095 |
| 110 | Colitis (HP:0002583) | 1.74585082 |
| 111 | Papilledema (HP:0001085) | 1.73388266 |
| 112 | Hematochezia (HP:0002573) | 1.73378319 |
| 113 | Peritonitis (HP:0002586) | 1.73091105 |
| 114 | * Epistaxis (HP:0000421) | 1.72630427 |
| 115 | Esophageal varix (HP:0002040) | 1.72320100 |
| 116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.71333216 |
| 117 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.71227542 |
| 118 | Urticaria (HP:0001025) | 1.70963663 |
| 119 | Gingivitis (HP:0000230) | 1.70664081 |
| 120 | Acute hepatic failure (HP:0006554) | 1.70564887 |
| 121 | Chronic otitis media (HP:0000389) | 1.69156926 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.69097644 |
| 123 | * Ureteral stenosis (HP:0000071) | 1.68146730 |
| 124 | Septate vagina (HP:0001153) | 1.67309992 |
| 125 | Myocardial infarction (HP:0001658) | 1.67017119 |
| 126 | Type I diabetes mellitus (HP:0100651) | 1.66810158 |
| 127 | Neutropenia (HP:0001875) | 1.65100438 |
| 128 | Basal cell carcinoma (HP:0002671) | 1.64764607 |
| 129 | Lymphoma (HP:0002665) | 1.64637860 |
| 130 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.63856503 |
| 131 | Acute myeloid leukemia (HP:0004808) | 1.60661470 |
| 132 | Bronchitis (HP:0012387) | 1.57939988 |
| 133 | Petechiae (HP:0000967) | 1.57328922 |
| 134 | Nasal polyposis (HP:0100582) | 1.54687895 |
| 135 | * Retinopathy (HP:0000488) | 1.51972386 |
| 136 | * Ureteral obstruction (HP:0006000) | 1.50825421 |
| 137 | Increased IgE level (HP:0003212) | 1.50438483 |
| 138 | Metabolic alkalosis (HP:0200114) | 1.49547538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TXK | 6.81027659 |
| 2 | MAP4K1 | 5.15717277 |
| 3 | JAK3 | 4.18164395 |
| 4 | ITK | 3.80099603 |
| 5 | JAK1 | 3.24484320 |
| 6 | ZAP70 | 3.19533801 |
| 7 | FGFR4 | 2.84693561 |
| 8 | KDR | 2.61984860 |
| 9 | MAP3K14 | 2.57812646 |
| 10 | TEC | 2.36473340 |
| 11 | STK10 | 2.34018608 |
| 12 | RIPK4 | 2.21769300 |
| 13 | FGFR3 | 2.20107129 |
| 14 | TYK2 | 2.02816370 |
| 15 | EPHA3 | 1.94613234 |
| 16 | IKBKE | 1.85457699 |
| 17 | * LCK | 1.78211763 |
| 18 | SYK | 1.74677514 |
| 19 | HCK | 1.73746225 |
| 20 | EPHB1 | 1.66965935 |
| 21 | PRKCQ | 1.50833095 |
| 22 | TRIB3 | 1.49802385 |
| 23 | BTK | 1.47252139 |
| 24 | CAMKK2 | 1.39358690 |
| 25 | TBK1 | 1.35008450 |
| 26 | ALK | 1.33994866 |
| 27 | GRK7 | 1.29658094 |
| 28 | CDK6 | 1.29641127 |
| 29 | PASK | 1.29410871 |
| 30 | NLK | 1.21641629 |
| 31 | IKBKB | 1.21555153 |
| 32 | STK24 | 1.20391268 |
| 33 | PRKCH | 1.16925263 |
| 34 | CSK | 1.14899402 |
| 35 | * JAK2 | 1.12912017 |
| 36 | FES | 1.12849744 |
| 37 | GRK6 | 1.09755611 |
| 38 | CHUK | 1.09630479 |
| 39 | MAP3K7 | 1.08751831 |
| 40 | EEF2K | 1.05870912 |
| 41 | TYRO3 | 1.04576459 |
| 42 | ADRBK2 | 1.01910150 |
| 43 | PRPF4B | 1.01150979 |
| 44 | PDK1 | 1.00082240 |
| 45 | MST4 | 0.96334183 |
| 46 | MAPK11 | 0.93457424 |
| 47 | LRRK2 | 0.90804007 |
| 48 | IRAK1 | 0.88086806 |
| 49 | CAMKK1 | 0.82377169 |
| 50 | CDK12 | 0.79148755 |
| 51 | BMPR2 | 0.77869888 |
| 52 | HIPK2 | 0.77551213 |
| 53 | SIK2 | 0.77365633 |
| 54 | CDK4 | 0.75955245 |
| 55 | IRAK4 | 0.75316752 |
| 56 | MAP3K13 | 0.75001793 |
| 57 | MARK3 | 0.74805977 |
| 58 | TAOK3 | 0.74348932 |
| 59 | PDPK1 | 0.68694348 |
| 60 | TNK2 | 0.67332204 |
| 61 | PDGFRB | 0.66228406 |
| 62 | PIM1 | 0.65167515 |
| 63 | MAPK15 | 0.65141378 |
| 64 | BCR | 0.62044013 |
| 65 | NME2 | 0.61363681 |
| 66 | MAPK4 | 0.61116208 |
| 67 | PKN2 | 0.60887029 |
| 68 | MAPK12 | 0.59680813 |
| 69 | LYN | 0.59567495 |
| 70 | MAP2K6 | 0.59338302 |
| 71 | BUB1 | 0.58544543 |
| 72 | RET | 0.58017097 |
| 73 | PTK6 | 0.57050841 |
| 74 | KIT | 0.55134597 |
| 75 | DMPK | 0.54976131 |
| 76 | FGFR1 | 0.53955361 |
| 77 | CDK9 | 0.53670469 |
| 78 | MAPKAPK3 | 0.53040033 |
| 79 | MELK | 0.50458964 |
| 80 | IGF1R | 0.48657124 |
| 81 | TLK1 | 0.48528858 |
| 82 | VRK1 | 0.47326571 |
| 83 | CLK1 | 0.46723004 |
| 84 | TAOK1 | 0.44347401 |
| 85 | IRAK2 | 0.43632179 |
| 86 | PIK3CA | 0.41647772 |
| 87 | INSR | 0.39803976 |
| 88 | MAP3K10 | 0.39719441 |
| 89 | CSNK1D | 0.39292978 |
| 90 | ABL1 | 0.38264348 |
| 91 | RPS6KA4 | 0.38255205 |
| 92 | WNK1 | 0.38052420 |
| 93 | NUAK1 | 0.36903455 |
| 94 | NEK9 | 0.36703150 |
| 95 | MAP3K1 | 0.35535097 |
| 96 | * FYN | 0.32546014 |
| 97 | EIF2AK3 | 0.31308397 |
| 98 | SIK3 | 0.30337701 |
| 99 | PIK3CG | 0.29898547 |
| 100 | TGFBR2 | 0.29817212 |
| 101 | WNK4 | 0.27987587 |
| 102 | CSF1R | 0.27722503 |
| 103 | TTN | 0.27362692 |
| 104 | MAPK3 | 0.27177662 |
| 105 | ROCK2 | 0.25714400 |
| 106 | EGFR | 0.25281674 |
| 107 | MAPK7 | 0.24875082 |
| 108 | RPS6KB1 | 0.24802339 |
| 109 | MAPKAPK2 | 0.22809365 |
| 110 | CSNK1A1L | 0.22617044 |
| 111 | BLK | 0.21653985 |
| 112 | MAP3K8 | 0.21195590 |
| 113 | MAPK9 | 0.20877265 |
| 114 | SIK1 | 0.20456294 |
| 115 | MAPK10 | 0.19530220 |
| 116 | RPS6KA5 | 0.19180516 |
| 117 | NME1 | 0.19149630 |
| 118 | SRC | 0.18988400 |
| 119 | SGK3 | 0.18675499 |
| 120 | PRKCB | 0.17606711 |
| 121 | DYRK1B | 0.17482404 |
| 122 | TESK2 | 0.17449515 |
| 123 | SMG1 | 0.16682258 |
| 124 | RAF1 | 0.16477417 |
| 125 | MAPK1 | 0.16402408 |
| 126 | MAP3K5 | 0.15689251 |
| 127 | BMX | 0.15017733 |
| 128 | MAP3K12 | 0.14914649 |
| 129 | GRK1 | 0.14720127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 6.94441051 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 6.62398713 |
| 3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 5.38328973 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.93498975 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 4.50896583 |
| 6 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.24512733 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.20517993 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80401557 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.24098998 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.09492094 |
| 11 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02744526 |
| 12 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.96535128 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.89258700 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85787867 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.75201970 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.47221603 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41345321 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38170722 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26092028 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19377503 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18261788 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08876143 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.07653891 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03171280 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98760668 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94324882 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76706337 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 0.71972523 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71427995 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 0.68400344 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68085078 |
| 32 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67202785 |
| 33 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67061930 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66090097 |
| 35 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65582542 |
| 36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64581758 |
| 37 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64568241 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 0.63190153 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59601850 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 0.58733464 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58621285 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57194771 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56795214 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 0.55671458 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54080540 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52091368 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51444924 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50753531 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50095125 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50093400 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48683195 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47804874 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 0.46146763 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45146086 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42660519 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40196508 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38857805 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38825763 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.38707041 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.37306666 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36019068 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.34932149 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33202478 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32519477 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32306892 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31448839 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30704450 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.30514394 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29474547 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28906515 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28010999 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27891276 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27081861 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26591872 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26291977 |
| 76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26119629 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25157878 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23791137 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.23670000 |
| 80 | Protein export_Homo sapiens_hsa03060 | 0.23025631 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21454212 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.21417884 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.21086795 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21039208 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.20528082 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20243485 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19563879 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19513515 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.19295261 |
| 90 | Spliceosome_Homo sapiens_hsa03040 | 0.18735057 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18052106 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.17280546 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16955966 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.16645843 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.16526307 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16398556 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.15526411 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.14194055 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14112606 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13345546 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12550465 |
| 102 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.09774835 |
| 103 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.07973252 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.07655314 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.06828878 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.06196694 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.06108574 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.05889707 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.05481878 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05280514 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.04909606 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.04653262 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.03780612 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03709532 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03596578 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.03427136 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.03154160 |
| 118 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.02648581 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.02280578 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.02161756 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.01902411 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.01421719 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.01243106 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0140392 |

